Overview
Patrick Gagnon is a Radiation Oncologist in Fall River, Massachusetts. Dr. Gagnon is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Posterior Fossa Tumor. Dr. Gagnon is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
534 Prospect St, Fall River, MA 02720
Brigham And Women's Hospital, Department Of Radiation Oncology
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Brigham And Women's Hospital, Department Of Radiation Oncology
David Kozono is a Radiation Oncologist in Boston, Massachusetts. Dr. Kozono is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Southcoast Physicians Group Inc
Tushar Kumar is a Radiation Oncologist in Fall River, Massachusetts. Dr. Kumar is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Anal Cancer. Dr. Kumar is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Gagnon isDistinguished. Learn about Familial Prostate Cancer.
- Laryngeal CancerDr. Gagnon isDistinguished. Learn about Laryngeal Cancer.
- Lung CancerDr. Gagnon isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Gagnon isDistinguished. Learn about Pleuropulmonary Blastoma.
- Posterior Fossa TumorDr. Gagnon isDistinguished. Learn about Posterior Fossa Tumor.
- Small Cell Lung Cancer (SCLC)Dr. Gagnon isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- Adult Soft Tissue SarcomaDr. Gagnon isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Gagnon isAdvanced. Learn about Anal Cancer.
- AngiosarcomaDr. Gagnon isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Gagnon isAdvanced. Learn about Breast Cancer.
- EGFR Positive Lung CancerDr. Gagnon isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Acoustic NeuromaDr. Gagnon isExperienced. Learn about Acoustic Neuroma.
- Alveolar Soft Part SarcomaDr. Gagnon isExperienced. Learn about Alveolar Soft Part Sarcoma.
- AstrocytomaDr. Gagnon isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Gagnon isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Bone TumorDr. Gagnon isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Gagnon isExperienced. Learn about Brain Tumor.

